News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
MEDA: Year-End Report January–December 2013
February 19, 2014
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Regulatory News:
MEDA(STO:MEDAA):
January-December 2013
•Group net sales reached SEK 13,114 million (12,991), corresponding to organic growth[1] of 4% compared to last year.
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless
October 8, 2025
·
69 min read
·
BioSpace Editorial Staff
IPOs
UPDATE: MapLight Seeks $227M IPO for Neuropsych Portfolio
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Beat Out Two Other Metsera Suitors for Takeover
October 7, 2025
·
3 min read
·
Tristan Manalac
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
October 7, 2025
·
2 min read
·
Tristan Manalac